[go: up one dir, main page]

MX9200803A - PERHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS NEUROLEPTICAS. - Google Patents

PERHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS NEUROLEPTICAS.

Info

Publication number
MX9200803A
MX9200803A MX9200803A MX9200803A MX9200803A MX 9200803 A MX9200803 A MX 9200803A MX 9200803 A MX9200803 A MX 9200803A MX 9200803 A MX9200803 A MX 9200803A MX 9200803 A MX9200803 A MX 9200803A
Authority
MX
Mexico
Prior art keywords
alkyl
pyrazinas
neurolepticas
pirido
perhydro
Prior art date
Application number
MX9200803A
Other languages
English (en)
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Original Assignee
Pfzier Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfzier Inc filed Critical Pfzier Inc
Publication of MX9200803A publication Critical patent/MX9200803A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX9200803A 1991-02-27 1992-02-25 PERHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS NEUROLEPTICAS. MX9200803A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/661,791 US5157034A (en) 1991-02-27 1991-02-27 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines

Publications (1)

Publication Number Publication Date
MX9200803A true MX9200803A (es) 1992-08-31

Family

ID=24655130

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200803A MX9200803A (es) 1991-02-27 1992-02-25 PERHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS NEUROLEPTICAS.

Country Status (24)

Country Link
US (1) US5157034A (es)
EP (1) EP0573467B1 (es)
JP (1) JP2546770B2 (es)
KR (1) KR0163413B1 (es)
AT (1) ATE123284T1 (es)
AU (1) AU652422B2 (es)
CA (2) CA2163274C (es)
DE (2) DE69110135T2 (es)
DK (1) DK0573467T3 (es)
ES (1) ES2073914T3 (es)
FI (3) FI105030B (es)
HU (1) HU216637B (es)
IE (1) IE67190B1 (es)
IL (2) IL112325A (es)
MX (1) MX9200803A (es)
MY (1) MY108185A (es)
NO (1) NO300847B1 (es)
NZ (1) NZ241739A (es)
PT (1) PT100160B (es)
RU (1) RU2090565C1 (es)
TW (1) TW207540B (es)
WO (1) WO1992015580A1 (es)
YU (1) YU48311B (es)
ZA (1) ZA921405B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69218414T2 (de) * 1991-02-27 1998-01-22 Pfizer Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
ES2137986T3 (es) * 1992-06-16 2000-01-01 Pfizer Procedimiento y productos intermedios para agentes ansioliticos bis-aza-biciclicos.
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
AU681310B2 (en) * 1994-09-30 1997-08-21 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
WO2004081007A1 (en) * 2003-03-12 2004-09-23 Pfizer Products Inc. Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
ES2563304T3 (es) * 2003-04-24 2016-03-14 Incyte Holdings Corporation Derivados azaespiro alcano como inhibidores de metaloproteasas
WO2007143600A2 (en) * 2006-06-05 2007-12-13 Incyte Corporation Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
EP0573467B1 (en) 1995-05-31
YU48311B (sh) 1998-05-15
RU2090565C1 (ru) 1997-09-20
DE69110135T2 (de) 1995-10-19
CA2163274C (en) 1999-02-09
NO300847B1 (no) 1997-08-04
EP0573467A1 (en) 1993-12-15
FI114214B (fi) 2004-09-15
KR930703315A (ko) 1993-11-29
AU652422B2 (en) 1994-08-25
IE920601A1 (en) 1992-09-09
ATE123284T1 (de) 1995-06-15
HU9302427D0 (en) 1993-11-29
NO933049D0 (no) 1993-08-26
NO933049L (no) 1993-08-26
TW207540B (es) 1993-06-11
HU216637B (hu) 1999-07-28
CA2101518C (en) 1997-11-25
IE67190B1 (en) 1996-03-06
PT100160B (pt) 1999-09-30
MY108185A (en) 1996-08-30
FI20030361L (fi) 2003-03-11
DK0573467T3 (da) 1995-10-09
ES2073914T3 (es) 1995-08-16
US5157034A (en) 1992-10-20
IL112325A (en) 1997-08-14
YU19892A (sh) 1994-11-15
ZA921405B (en) 1993-08-26
DE9190206U1 (de) 1993-10-14
AU1259992A (en) 1992-10-06
IL112325A0 (en) 1995-03-30
HUT66965A (en) 1995-01-30
FI933753L (fi) 1993-08-26
NZ241739A (en) 1994-07-26
PT100160A (pt) 1993-05-31
JP2546770B2 (ja) 1996-10-23
FI112865B (fi) 2004-01-30
JPH06500120A (ja) 1994-01-06
CA2163274A1 (en) 1992-08-28
KR0163413B1 (ko) 1998-12-01
IL101021A (en) 1996-03-31
DE69110135D1 (de) 1995-07-06
FI933753A0 (fi) 1993-08-26
FI20000354L (fi) 2000-02-17
FI105030B (fi) 2000-05-31
WO1992015580A1 (en) 1992-09-17
CA2101518A1 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
MX9200803A (es) PERHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS NEUROLEPTICAS.
ATE130850T1 (de) Fulgimidderivate.
ATE124699T1 (de) Tricyclische carbapenemverbindungen.
DK0546583T3 (da) Piperidinyl- og piperazinylcyclohexanoler
ES2116555T3 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69217877D1 (de) Feste kosmetische Zusammensetzung auf Öl-Basis
FI922561A0 (fi) Derivat av 1-metylkarbapenem, deras framstaellning och anvaendning som antibiotika.
FI924869A0 (fi) Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
ES2083501T3 (es) Sintesis de 2-aril-5-(fluormetil)pirroles utiles como agentes pesticidas y como compuestos intermedios para la preparacion de dichos agentes.
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
ATE176230T1 (de) Spiropyran-derivate mit photochromischen eigenschaften
DE69708198D1 (de) Muscarinische Rezeptor-Agonisten
ES2052807T3 (es) Tienil-piperazinonas, su obtencion y empleo.
FI810618L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
DK0445013T3 (da) N-Cycloalkylalkylaminer, fremgangsmåde til fremstilling deraf, deres anvendelse som lægemiddel og deres syntese-mellemprodukter
TW337983B (en) 1, 3-oxazn-4-one derivatives, their preparation and uses
ATE121394T1 (de) Konjugierte gamma-hydroxybutenolid-derivate und sie als aktiver wirkstoff enthaltende mittel gegen magengeschwüre.
FI77022B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrrolaettiksyraderivat.
CA2177392A1 (en) Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
KR920021814U (ko) 오븐렌지의 캐비티 내부구조
ES8900014A1 (es) Un procedimiento para la preparacion de derivados del acido 1-(fenil-sustituido)-4-carboxi-naftalen-2-carboxilico.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees